OFSA3 Statistics
Total Valuation
Ouro Fino Saúde Animal Participações has a market cap or net worth of BRL 1.22 billion. The enterprise value is 1.32 billion.
Market Cap | 1.22B |
Enterprise Value | 1.32B |
Important Dates
The last earnings date was Thursday, November 7, 2024.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | Jan 2, 2025 |
Share Statistics
Ouro Fino Saúde Animal Participações has 53.77 million shares outstanding. The number of shares has increased by 0.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 53.77M |
Shares Change (YoY) | +0.00% |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 56.48% |
Owned by Institutions (%) | 3.74% |
Float | 7.52M |
Valuation Ratios
The trailing PE ratio is 13.37.
PE Ratio | 13.37 |
Forward PE | n/a |
PS Ratio | 1.27 |
PB Ratio | 1.67 |
P/TBV Ratio | n/a |
P/FCF Ratio | 24.89 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.84, with an EV/FCF ratio of 26.93.
EV / Earnings | 14.47 |
EV / Sales | 1.37 |
EV / EBITDA | 7.84 |
EV / EBIT | 9.41 |
EV / FCF | 26.93 |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.49.
Current Ratio | 3.51 |
Quick Ratio | 2.33 |
Debt / Equity | 0.49 |
Debt / EBITDA | 2.14 |
Debt / FCF | 7.33 |
Interest Coverage | 7.81 |
Financial Efficiency
Return on equity (ROE) is 13.02% and return on invested capital (ROIC) is 8.29%.
Return on Equity (ROE) | 13.02% |
Return on Assets (ROA) | 6.79% |
Return on Capital (ROIC) | 8.29% |
Revenue Per Employee | 797,633 |
Profits Per Employee | 75,757 |
Employee Count | 1,202 |
Asset Turnover | 0.74 |
Inventory Turnover | 1.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.28% in the last 52 weeks. The beta is 1.08, so Ouro Fino Saúde Animal Participações's price volatility has been similar to the market average.
Beta (5Y) | 1.08 |
52-Week Price Change | +3.28% |
50-Day Moving Average | 21.51 |
200-Day Moving Average | 21.41 |
Relative Strength Index (RSI) | 62.92 |
Average Volume (20 Days) | 5,455 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ouro Fino Saúde Animal Participações had revenue of BRL 958.76 million and earned 91.06 million in profits. Earnings per share was 1.69.
Revenue | 958.76M |
Gross Profit | 465.02M |
Operating Income | 139.99M |
Pretax Income | 136.52M |
Net Income | 91.06M |
EBITDA | 165.00M |
EBIT | 139.99M |
Earnings Per Share (EPS) | 1.69 |
Balance Sheet
The company has 259.28 million in cash and 358.81 million in debt, giving a net cash position of -99.53 million or -1.85 per share.
Cash & Cash Equivalents | 259.28M |
Total Debt | 358.81M |
Net Cash | -99.53M |
Net Cash Per Share | -1.85 |
Equity (Book Value) | 728.99M |
Book Value Per Share | 13.56 |
Working Capital | 600.00M |
Cash Flow
In the last 12 months, operating cash flow was 65.28 million and capital expenditures -16.36 million, giving a free cash flow of 48.92 million.
Operating Cash Flow | 65.28M |
Capital Expenditures | -16.36M |
Free Cash Flow | 48.92M |
FCF Per Share | 0.91 |
Margins
Gross margin is 48.50%, with operating and profit margins of 14.60% and 9.50%.
Gross Margin | 48.50% |
Operating Margin | 14.60% |
Pretax Margin | 14.24% |
Profit Margin | 9.50% |
EBITDA Margin | 17.21% |
EBIT Margin | 14.60% |
FCF Margin | 5.10% |
Dividends & Yields
This stock pays an annual dividend of 0.67, which amounts to a dividend yield of 2.97%.
Dividend Per Share | 0.67 |
Dividend Yield | 2.97% |
Dividend Growth (YoY) | -3.50% |
Years of Dividend Growth | n/a |
Payout Ratio | 34.04% |
Buyback Yield | -0.00% |
Shareholder Yield | 2.97% |
Earnings Yield | 7.48% |
FCF Yield | 4.02% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Ouro Fino Saúde Animal Participações has an Altman Z-Score of 2.96. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.96 |
Piotroski F-Score | n/a |